logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > 2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-

2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1234480-84-2

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1234480-84-2
Appearance ::
Solid
Molecular Formula::
C31H38N8O3
Molecular Weight::
570.69
EINECS NO::
N/A
MDL NO::
MFCD22683805
CAS NO::
1234480-84-2
Appearance ::
Solid
Molecular Formula::
C31H38N8O3
Molecular Weight::
570.69
EINECS NO::
N/A
MDL NO::
MFCD22683805
2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-

Product Description:

Product Name: 2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5,11-dimethylpyrimido[4,5-b][1,4]benzodiazepin-6-one CAS 1234480-84-2

 

 

 

 

 

 

 

Synonyms:

LRRK2-IN-1;

 

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance : Solid

Assay :≥98.0%

Density:1.3 g/cm3

Boiling Point:787.8℃ at 760 mmHg

Flash Point:430.3℃

 

 

 

 

 

 

 

 

LRRK2-IN-1 is a benzodiazepine based derivative and is known as a selective inhibitor of the Parkinson's disease kinase LRRK2.

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.